ENSC
Ensysce Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.46
+3.57%Leverage
- Debt / equity
- -0.25x
- Net debt / equity
- 0.61x
- Debt / assets
- 0.07x
- Debt / EBITDA
- -0.02x
- Net debt / EBITDA
- 0.04x
Liquidity & coverage
- Current ratio
- 0.70x
- Quick ratio
- 0.70x
- Cash ratio
- 0.17x
- Interest coverage
- -791.64x
- EBITDA / interest
- -788.64x
- Working capital
- -$1.2M
Cash & dividend
- FCF / debt
- -45.62x
- Cash flow / debt
- -44.99x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026